Dr. Augert is named a V Scholar by the V Foundation. With the support of the V Foundation, Dr. Augert and his team will dissect the transcriptional and epigenetic mechanisms underlying SCLC initiation and progression.

Dr. Augert is awarded a Yale SPORE in Lung Cancer (YSILC) Career Enhancement Program (CEP). The proposed work will attempt to understand and target PBRM1 mutant small cell lung cancers.

Dr. Augert is awarded a K12 Calabresi Immuno-Oncology Training Program (IOTP) to study the role of a chromatin remodeling complex in the regulation of the tumor microenvironment and anti-tumor immunity.